Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypertension | 15 | 2019 | 972 | 2.350 |
Why?
|
Blood Pressure | 8 | 2019 | 859 | 1.570 |
Why?
|
Erectile Dysfunction | 2 | 2019 | 56 | 1.310 |
Why?
|
Antihypertensive Agents | 7 | 2019 | 362 | 1.100 |
Why?
|
Penile Erection | 2 | 2019 | 22 | 0.870 |
Why?
|
Motor Activity | 4 | 2010 | 327 | 0.830 |
Why?
|
Sexual Dysfunction, Physiological | 2 | 2016 | 13 | 0.700 |
Why?
|
Cardiovascular Diseases | 6 | 2019 | 1133 | 0.590 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2016 | 8 | 0.570 |
Why?
|
Aged | 23 | 2019 | 10398 | 0.560 |
Why?
|
Middle Aged | 25 | 2019 | 11949 | 0.560 |
Why?
|
Male | 27 | 2019 | 19488 | 0.480 |
Why?
|
Quality of Life | 5 | 2016 | 915 | 0.470 |
Why?
|
African Americans | 6 | 2016 | 1443 | 0.450 |
Why?
|
Social Behavior | 1 | 2013 | 65 | 0.440 |
Why?
|
Exercise | 3 | 2016 | 655 | 0.420 |
Why?
|
Sexual Behavior | 3 | 2019 | 106 | 0.410 |
Why?
|
Cross-Sectional Studies | 9 | 2019 | 1522 | 0.410 |
Why?
|
Life Style | 3 | 2010 | 404 | 0.400 |
Why?
|
Obesity | 2 | 2010 | 1164 | 0.400 |
Why?
|
Female | 27 | 2019 | 20126 | 0.390 |
Why?
|
Systole | 4 | 2019 | 100 | 0.390 |
Why?
|
Intra-Abdominal Fat | 2 | 2009 | 66 | 0.390 |
Why?
|
Ethnic Groups | 3 | 2019 | 480 | 0.390 |
Why?
|
Humans | 30 | 2019 | 32297 | 0.380 |
Why?
|
Exercise Therapy | 3 | 2015 | 259 | 0.370 |
Why?
|
Atherosclerosis | 4 | 2014 | 770 | 0.370 |
Why?
|
United States | 8 | 2019 | 3983 | 0.350 |
Why?
|
Health Status | 3 | 2017 | 402 | 0.340 |
Why?
|
Insulin Resistance | 3 | 2008 | 460 | 0.330 |
Why?
|
Aging | 2 | 2013 | 953 | 0.330 |
Why?
|
Pain | 2 | 2015 | 305 | 0.330 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2010 | 142 | 0.320 |
Why?
|
Incidence | 3 | 2019 | 1207 | 0.310 |
Why?
|
Health Promotion | 5 | 2013 | 242 | 0.270 |
Why?
|
Accidental Falls | 2 | 2019 | 219 | 0.270 |
Why?
|
Occupational Diseases | 2 | 2019 | 81 | 0.270 |
Why?
|
Patient Care Planning | 2 | 2018 | 58 | 0.260 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2015 | 1428 | 0.260 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2019 | 511 | 0.260 |
Why?
|
Hispanic Americans | 4 | 2017 | 949 | 0.260 |
Why?
|
Osteoarthritis, Knee | 1 | 2005 | 89 | 0.250 |
Why?
|
Prevalence | 5 | 2019 | 986 | 0.230 |
Why?
|
Adult | 8 | 2016 | 9467 | 0.210 |
Why?
|
Smoking | 1 | 2005 | 493 | 0.200 |
Why?
|
Exercise Tolerance | 3 | 2010 | 123 | 0.190 |
Why?
|
Disability Evaluation | 3 | 2013 | 236 | 0.180 |
Why?
|
Work Schedule Tolerance | 3 | 2019 | 10 | 0.180 |
Why?
|
Sex Factors | 3 | 2018 | 674 | 0.180 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2019 | 19 | 0.180 |
Why?
|
Sodium | 1 | 2019 | 39 | 0.170 |
Why?
|
Acute Coronary Syndrome | 2 | 2018 | 189 | 0.170 |
Why?
|
Men's Health | 1 | 2019 | 11 | 0.170 |
Why?
|
Subcutaneous Fat | 2 | 2009 | 46 | 0.160 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2016 | 141 | 0.160 |
Why?
|
Odds Ratio | 1 | 2019 | 480 | 0.150 |
Why?
|
Myocardial Infarction | 2 | 2018 | 469 | 0.150 |
Why?
|
Glucose Intolerance | 2 | 2008 | 47 | 0.140 |
Why?
|
Risk Factors | 4 | 2015 | 3876 | 0.140 |
Why?
|
Risk Reduction Behavior | 3 | 2015 | 124 | 0.140 |
Why?
|
Diet | 3 | 2015 | 384 | 0.140 |
Why?
|
Physical Fitness | 3 | 2010 | 127 | 0.140 |
Why?
|
Skin Care | 1 | 2016 | 13 | 0.140 |
Why?
|
Behavior Therapy | 2 | 2010 | 102 | 0.140 |
Why?
|
Hair | 1 | 2016 | 28 | 0.140 |
Why?
|
Coronary Artery Disease | 1 | 2019 | 397 | 0.130 |
Why?
|
Scalp | 1 | 2016 | 38 | 0.130 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 759 | 0.130 |
Why?
|
Workload | 2 | 2014 | 40 | 0.130 |
Why?
|
Stroke | 2 | 2018 | 585 | 0.130 |
Why?
|
Heart Failure | 2 | 2018 | 630 | 0.130 |
Why?
|
Kidney Diseases | 1 | 2018 | 255 | 0.130 |
Why?
|
Socioeconomic Factors | 2 | 2017 | 422 | 0.120 |
Why?
|
Geriatric Assessment | 2 | 2016 | 395 | 0.120 |
Why?
|
Brachial Artery | 1 | 2014 | 68 | 0.120 |
Why?
|
Caloric Restriction | 1 | 2015 | 96 | 0.120 |
Why?
|
Time Factors | 1 | 2019 | 2181 | 0.120 |
Why?
|
Vasodilation | 1 | 2014 | 93 | 0.120 |
Why?
|
Logistic Models | 1 | 2016 | 788 | 0.120 |
Why?
|
Aged, 80 and over | 7 | 2019 | 4050 | 0.120 |
Why?
|
Knee Joint | 1 | 2015 | 142 | 0.120 |
Why?
|
Endothelium, Vascular | 1 | 2014 | 154 | 0.110 |
Why?
|
Overweight | 1 | 2015 | 270 | 0.110 |
Why?
|
Stress, Psychological | 1 | 2014 | 218 | 0.110 |
Why?
|
Motivation | 1 | 2013 | 114 | 0.110 |
Why?
|
Urban Population | 1 | 2013 | 87 | 0.100 |
Why?
|
Ankle Brachial Index | 1 | 2012 | 39 | 0.100 |
Why?
|
Quality of Health Care | 1 | 2013 | 151 | 0.100 |
Why?
|
Food | 1 | 2011 | 43 | 0.100 |
Why?
|
Weight Loss | 2 | 2015 | 454 | 0.100 |
Why?
|
Knee | 1 | 2010 | 33 | 0.090 |
Why?
|
Prospective Studies | 2 | 2006 | 2274 | 0.090 |
Why?
|
Respiratory Function Tests | 2 | 2010 | 122 | 0.090 |
Why?
|
Abdominal Fat | 1 | 2008 | 48 | 0.080 |
Why?
|
Sex Distribution | 1 | 2008 | 201 | 0.080 |
Why?
|
Algorithms | 1 | 2010 | 497 | 0.070 |
Why?
|
Child Behavior Disorders | 1 | 2006 | 11 | 0.070 |
Why?
|
Chi-Square Distribution | 1 | 2006 | 302 | 0.060 |
Why?
|
Energy Metabolism | 1 | 2006 | 147 | 0.060 |
Why?
|
Pediatrics | 1 | 2006 | 158 | 0.060 |
Why?
|
Cytokines | 1 | 2006 | 262 | 0.060 |
Why?
|
Genotype | 1 | 2006 | 742 | 0.060 |
Why?
|
Body Composition | 1 | 2006 | 384 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2019 | 293 | 0.060 |
Why?
|
Psychotherapy, Group | 1 | 2003 | 17 | 0.060 |
Why?
|
Counseling | 1 | 2003 | 99 | 0.050 |
Why?
|
African Continental Ancestry Group | 2 | 2017 | 364 | 0.050 |
Why?
|
European Continental Ancestry Group | 2 | 2017 | 1180 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2017 | 3358 | 0.050 |
Why?
|
Activities of Daily Living | 2 | 2016 | 258 | 0.040 |
Why?
|
Cohort Studies | 2 | 2015 | 1832 | 0.040 |
Why?
|
Regression Analysis | 1 | 2019 | 296 | 0.040 |
Why?
|
Up-Regulation | 1 | 2019 | 196 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2019 | 470 | 0.040 |
Why?
|
North Carolina | 2 | 2013 | 1520 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2019 | 786 | 0.040 |
Why?
|
Linear Models | 2 | 2012 | 454 | 0.040 |
Why?
|
Hypotension, Orthostatic | 1 | 2016 | 12 | 0.040 |
Why?
|
Drug Therapy, Combination | 1 | 2017 | 301 | 0.040 |
Why?
|
Demography | 1 | 2016 | 109 | 0.030 |
Why?
|
Cross-Cultural Comparison | 1 | 2016 | 27 | 0.030 |
Why?
|
Continental Population Groups | 1 | 2017 | 239 | 0.030 |
Why?
|
Hypotension | 1 | 2016 | 49 | 0.030 |
Why?
|
Young Adult | 2 | 2016 | 2626 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2017 | 245 | 0.030 |
Why?
|
Medication Adherence | 1 | 2017 | 161 | 0.030 |
Why?
|
Professional Autonomy | 1 | 2014 | 6 | 0.030 |
Why?
|
Occupations | 1 | 2014 | 10 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 2014 | 89 | 0.030 |
Why?
|
Comorbidity | 1 | 2016 | 572 | 0.030 |
Why?
|
Sodium Chloride Symporter Inhibitors | 1 | 2014 | 10 | 0.030 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2014 | 11 | 0.030 |
Why?
|
Calcium Channel Blockers | 1 | 2014 | 49 | 0.030 |
Why?
|
Asian Americans | 1 | 2014 | 100 | 0.030 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2014 | 62 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2014 | 100 | 0.030 |
Why?
|
Restaurants | 1 | 2011 | 7 | 0.030 |
Why?
|
Body Mass Index | 1 | 2015 | 921 | 0.030 |
Why?
|
Vegetables | 1 | 2011 | 35 | 0.030 |
Why?
|
Fruit | 1 | 2011 | 53 | 0.020 |
Why?
|
Social Environment | 1 | 2011 | 80 | 0.020 |
Why?
|
Focus Groups | 1 | 2011 | 111 | 0.020 |
Why?
|
Dietary Fats | 1 | 2011 | 110 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2012 | 696 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2011 | 190 | 0.020 |
Why?
|
Health Behavior | 1 | 2011 | 229 | 0.020 |
Why?
|
Minority Groups | 1 | 2009 | 76 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2009 | 410 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2006 | 140 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2009 | 920 | 0.010 |
Why?
|
Self Efficacy | 1 | 2003 | 78 | 0.010 |
Why?
|
Sickness Impact Profile | 1 | 2002 | 37 | 0.010 |
Why?
|
Physical Endurance | 1 | 2002 | 35 | 0.010 |
Why?
|
Internship and Residency | 1 | 2006 | 306 | 0.010 |
Why?
|
Probability | 1 | 2002 | 160 | 0.010 |
Why?
|
Reference Values | 1 | 2002 | 255 | 0.010 |
Why?
|
Chronic Disease | 1 | 2003 | 406 | 0.010 |
Why?
|
Patient Compliance | 1 | 2002 | 227 | 0.010 |
Why?
|
Child | 1 | 2006 | 2472 | 0.010 |
Why?
|
Age Factors | 1 | 2002 | 1204 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2002 | 926 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2006 | 3514 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2002 | 2296 | 0.010 |
Why?
|
Risk Assessment | 1 | 2002 | 1447 | 0.010 |
Why?
|